Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Holly Maples

Concepts (95)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Vancomycin
8
2023
81
2.440
Why?
Methicillin-Resistant Staphylococcus aureus
7
2023
76
1.590
Why?
Anti-Bacterial Agents
12
2023
747
1.430
Why?
Staphylococcal Infections
7
2023
269
1.190
Why?
Area Under Curve
5
2021
178
0.420
Why?
Microbial Sensitivity Tests
4
2021
270
0.370
Why?
Pediatrics
2
2013
279
0.310
Why?
Triazoles
2
2005
109
0.280
Why?
Malaria
1
2006
37
0.270
Why?
Pyrimidines
2
2005
193
0.260
Why?
Drug Monitoring
3
2020
78
0.240
Why?
Antifungal Agents
2
2005
339
0.240
Why?
Referral and Consultation
1
2006
285
0.240
Why?
Trichosporon
1
2003
13
0.230
Why?
Child
11
2024
6851
0.230
Why?
Arthritis, Infectious
1
2024
45
0.220
Why?
Famotidine
1
2003
11
0.220
Why?
Histamine H2 Antagonists
1
2003
26
0.210
Why?
Osteomyelitis
1
2024
126
0.210
Why?
Mycoses
1
2003
158
0.210
Why?
Bacteremia
1
2023
92
0.200
Why?
Practice Guidelines as Topic
3
2020
449
0.200
Why?
Humans
19
2024
50208
0.200
Why?
Kidney Failure, Chronic
1
2003
200
0.180
Why?
Consensus
1
2021
150
0.180
Why?
Cystic Fibrosis
1
2022
149
0.180
Why?
Communicable Diseases
1
2020
55
0.170
Why?
Respiratory System
1
2015
26
0.130
Why?
Respiratory Tract Infections
1
2015
76
0.120
Why?
Tracheostomy
1
2015
71
0.120
Why?
Drug Utilization Review
1
2014
23
0.120
Why?
Inappropriate Prescribing
1
2013
18
0.110
Why?
United States
6
2020
4874
0.110
Why?
Drug Resistance, Bacterial
1
2013
71
0.110
Why?
Hospitals, Pediatric
1
2014
236
0.100
Why?
Infant
5
2015
3563
0.100
Why?
Pharmacists
2
2020
144
0.080
Why?
Plasmodium
1
2006
3
0.070
Why?
Geography
1
2006
60
0.070
Why?
Specialization
1
2006
46
0.070
Why?
Antimalarials
1
2006
23
0.070
Why?
Medicine
1
2006
56
0.070
Why?
Child, Preschool
4
2015
3883
0.060
Why?
Azithromycin
1
2005
25
0.060
Why?
Amphotericin B
1
2005
110
0.060
Why?
Antiretroviral Therapy, Highly Active
1
2004
34
0.060
Why?
Candidiasis
1
2005
114
0.060
Why?
HIV-1
1
2004
55
0.060
Why?
Treatment Refusal
1
2004
37
0.060
Why?
Mucorales
1
2024
11
0.060
Why?
Mucormycosis
1
2024
29
0.060
Why?
Micronesia
1
2024
111
0.060
Why?
Fatal Outcome
1
2003
195
0.050
Why?
Neutropenia
1
2003
115
0.050
Why?
Tissue Distribution
1
2003
163
0.050
Why?
Adolescent
3
2015
6390
0.050
Why?
Methicillin
1
2020
11
0.050
Why?
HIV Infections
1
2004
357
0.050
Why?
Societies, Pharmaceutical
1
2020
12
0.040
Why?
Staphylococcus aureus
1
2023
327
0.040
Why?
Aging
1
2005
688
0.040
Why?
Adult
1
2015
13324
0.040
Why?
Societies, Medical
1
2020
177
0.040
Why?
Lung
1
2022
490
0.040
Why?
Inflammation
1
2022
604
0.040
Why?
Acute Kidney Injury
1
2020
285
0.030
Why?
Pseudomonas Infections
1
2015
48
0.030
Why?
Pseudomonas aeruginosa
1
2015
72
0.030
Why?
Infusions, Intravenous
2
2005
213
0.030
Why?
Infant, Newborn
2
2015
2766
0.030
Why?
Feedback
1
2014
52
0.030
Why?
Government Regulation
1
2013
14
0.030
Why?
Infection Control
1
2013
49
0.030
Why?
Patient Safety
1
2013
102
0.030
Why?
Data Collection
1
2014
277
0.030
Why?
Male
3
2024
25399
0.030
Why?
Program Development
1
2013
167
0.030
Why?
Health Policy
1
2013
154
0.030
Why?
Female
3
2024
26635
0.030
Why?
Program Evaluation
1
2013
354
0.020
Why?
Animals
1
2006
13246
0.020
Why?
Prevalence
1
2014
951
0.020
Why?
Attitude of Health Personnel
1
2013
351
0.020
Why?
Retrospective Studies
2
2015
6134
0.020
Why?
Directly Observed Therapy
1
2004
8
0.020
Why?
Drug Resistance, Viral
1
2004
8
0.020
Why?
Foster Home Care
1
2004
14
0.020
Why?
Treatment Failure
1
2004
116
0.010
Why?
Viral Load
1
2004
77
0.010
Why?
RNA, Viral
1
2004
126
0.010
Why?
Chromatography, High Pressure Liquid
1
2005
327
0.010
Why?
Mass Spectrometry
1
2005
301
0.010
Why?
Home Care Services
1
2004
73
0.010
Why?
Child Abuse
1
2004
136
0.010
Why?
Infant, Premature
1
2005
319
0.010
Why?
Maples's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description